| Digestive System Neuroendocrine Tumor G1 studied in …STUDIED_INderived56 of 56show fewer |
|---|
| → studied in | NCT05773274Phase 2 · recruiting Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03375320Phase 3 · active not recruiting Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00569127Phase 3 · active not recruiting Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor · condition mapped ONTOLOGY_EXACT · 56 trials mapped (10 active) | — | — | Colorectal Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01841736Phase 2 · active not recruiting Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04993261early Phase 1 · active not recruiting An Investigational Scan (Dual Energy CT) in Detecting Gastrointestinal Carcinoid Tumors · condition mapped ONTOLOGY_EXACT · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06016855Phase 4 · recruiting Surgical Debulking Prior to Peptide Receptor Radionuclide Therapy in Well Differentiated Gastroenteropancreatic Neuroendocrine Tumors · condition mapped ONTOLOGY_EXACT · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07150546Phase 1 · recruiting Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors. · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04907643NA · recruiting Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07188441Phase 2 · recruiting Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Injection Combined With Cisplatin. · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04735198NA · recruiting Prophylactic Cholecystectomy in Midgut NETs Patients Who Require Primary Tumor Surgery. · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Midgut Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04197310Phase 2 · completed Cabozantinib and Nivolumab for Carcinoid Tumors · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05176665Phase 1/Phase 2 · unknown EMB-01 in Patients With Advanced/Metastatic Gastrointestinal Cancers · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00655655Phase 1 · completed Everolimus and Vatalanib in Treating Patients With Advanced Solid Tumors · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04602117Phase 1 · withdrawn ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02893930Phase 2 · completed Sapanisertib in Treating Patients With Metastatic or Refractory Pancreatic Neuroendocrine Tumor That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 56 trials mapped (10 active) | — | — | Pancreatic Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00427349Phase 2 · completed AMG 706 and Octreotide in Treating Patients With Low-Grade Neuroendocrine Tumors · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00227617Phase 2/Phase 3 · terminated Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine Tumors · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00396279Phase 2 · completed Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03722511Phase 2 · completed Evaluating an Amino Acid Based Medical Food w/ Diarrhea in Carcinoid Syndrome & Other NETs · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01229943Phase 2 · completed Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 56 trials mapped (10 active) | — | — | Pancreatic Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02259725Phase 2 · completed Regorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine Tumors · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02420691Phase 2 · completed Ribociclib in Treating Patients With Advanced Neuroendocrine Tumors of Foregut Origin · condition mapped ONTOLOGY_EXACT · 56 trials mapped (10 active) | — | — | Duodenal Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454363Phase 2 · completed Pazopanib Hydrochloride in Treating Patients With Advanced Neuroendocrine Cancer · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01010126Phase 2 · completed Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00019474Phase 2 · completed Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03622333NA · unknown Clinic, Pathologic and Genetic Characterization of Patients With Familial Carcinoid Tumors (Study From the GTE, Groupe d'étude Des Tumeurs Endocrines) · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Small Intestinal Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00903396Phase 2 · terminated Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00730483NA · terminated Doxorubicin Beads in Treating Patients With Unresectable Liver Metastases From Neuroendocrine Tumors · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00654160Phase 1 · completed Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00093782Phase 2 · completed Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01204476Phase 1 · completed Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade Neuroendocrine Carcinoma · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049023Phase 1 · completed Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01155258Phase 1 · completed Temsirolimus and Vinorelbine Ditartrate in Treating Patients With Unresectable or Metastatic Solid Tumors · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00416767Phase 2 · completed Combination Chemotherapy as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors of the Duodenum or Pancreas That Cannot Be Removed By Surgery · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00227773Phase 2 · withdrawn Vatalanib and Octreotide in Treating Patients With Progressive Neuroendocrine Tumors · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01548482Phase 1 · completed Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397384Phase 1 · completed Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00131911Phase 2 · completed Sorafenib Tosylate in Treating Patients With Progressive Metastatic Neuroendocrine Tumors · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002947Phase 1 · terminated Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01048892Phase 1 · completed Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00454376unknown Disease-Specific Questionnaire in Assessing Quality of Life in Patients With Gastrointestinal-Related Neuroendocrine Tumors · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00031681Phase 1 · completed 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00602082Phase 2 · completed Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003427Phase 1 · completed Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00027638Phase 2 · completed Thalidomide in Treating Patients With Metastatic Neuroendocrine Tumors · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00075439Phase 2 · completed Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00084461Phase 2 · terminated Romidepsin in Treating Patients With Locally Advanced or Metastatic Neuroendocrine Tumors · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00002470Phase 2 · completed Fluorouracil Plus Interferon Alfa in Treating Patients With Advanced Metastatic Carcinoid Tumors · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00006368Phase 1 · completed Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004074Phase 1 · completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00017199Phase 2 · completed PS-341 in Treating Patients With Metastatic Neuroendocrine Tumors · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00055809Phase 2 · completed Bevacizumab and PEG-Interferon Alfa-2b in Treating Patients With Metastatic or Unresectable Carcinoid Tumors · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00087191NA · terminated EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer · condition mapped CURATED_BROADER · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004910Phase 1/Phase 2 · completed Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004911Phase 1/Phase 2 · completed Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00005049Phase 2 · completed Combination Chemotherapy in Treating Patients With Stage III Ovarian Epithelial Cancer or Gastrointestinal Cancer · condition mapped ALIAS · 56 trials mapped (10 active) | — | — | Digestive System Neuroendocrine Tumor G1 | 1 | Observed | clinicaltrials | graph → |